Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
12.843 / 17.026
#102737

Re: Farmas USA

Announced that the first patient has been dosed in a Phase 1 clinical trial evaluating the safety and tolerability of its proprietary fully-human anti-PD-L1 monoclonal antibody.

Ains que brinco me he perdido cagon'sos

TGTX

Keryx price target raised to $34 from $25 at Mizuho
Mizuho believes investors are under appreciating the potential of this week's Doc Fix bill that delays oral bundling to 2024 from 2016. The firm significantly raised Keryx's Zerenex revenue forecast and now sees peak sales closer to $2B from $1B. The firm rates shares a Buy with a $34 price target, up from $25

KERX

#102738

Re: Farmas USA

TG Therapeutics (NASDAQ:TGTX) announces that the first patient has been dosed in a Phase 1 clinical trial evaluating the safety and tolerability of its fully-human anti-PD-L1 monoclonal antibody in checkpoint therapy-naïve patients with selected recurrent or metastatic cancers.
• Secondary endpoints include the evaluation or characterization of the pharmacokinetics, immunogenicity and preliminary efficacy.
• Shares are up 3% premarket on light volume.

#102740

Re: Farmas USA

HZNP

La quite de la watchlist de seguimiento para no perseguirla tras no subirme al tren a tiempo ( la verdad, me quede como las vacas viendo al tren pasar cuando sucedio ese super martillaco con volumen, a veces pasa ... ). Y por eso no me enteré de la oportunidad que dio hace un par de sesiones. 

En fin, viento en popa con esta y ya 14,15 en premarket ... veremos si esta vez se decide a cerrrar el gap ...

 

ains, para haberla sacado un paston ...

#102742

Re: Farmas USA

Hoy si me ha comprado a 1,15
NVAX

#102744

Re: Farmas USA

IBB

Estos cuando se remangan, cuidado. Puede pasar cualquier cosa!

Si te sientas en la mesa y no descubres al "primo" es que lo eres tú.